Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) Q2 2023 Earnings Call Transcript

Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) Q2 2023 Earnings Call Transcript August 8, 2023

Arcutis Biotherapeutics, Inc. misses on earnings expectations. Reported EPS is $-1.16 EPS, expectations were $1.22.

Operator: Good day and thank you for standing by. Welcome to the Arcutis Biotherapeutics Second Quarter 2023 Conference Call. At this time, all participants are in a listen-only mode. After the speakers’ presentation, there will be a question-and-answer session. [Operator Instructions]...